Skip to main content

Table 2 Comparison of Results from 2018 Dual vs Mono Antiplatelet Therapy and 2019 Meta-analyses

From: RETRACTED ARTICLE: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis

Results

Yang Et al. 2018 (RR; CI)

P value

Albay, Leyson 2019 (RR; CI)

P value

Stroke recurrence

RR 0.69, 95% CI: 0.61–0.78

< 0.001

RR 0.75, 95% CI:0.68–0.83

< 0.00001

Composite Events

RR 0.72, 95% CI: 0.64–0.80

<  0.001

0.73 95% CI: 0.65–0.82

<  0.00001

Major Bleeding

RR 1.77, 95% CI 1.09–2.87

0.02

1.22 95% CI: 0.87–1.70

0.25